Dr. Deng's research focuses on developing novel immune therapeutics against cancers; in particular, he is interested in the utilization of bioengineered fusion cytokines to reprogram patient immune cells for personalized cancer immunotherapy.
Titles and Roles
- Instructor, Department of Hematology and Medical Oncology
- Winship Cancer Institute of Emory University
- Research Program
- Discovery and Developmental Therapeutics
Jiusheng Deng is an Instructor at the Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine. Dr. Deng is an active member of American Society of Hematology, American Association of Cancer Research, and Society for Immunotherapy of Cancer.
Dr. Deng received his PhD from Tel Aviv University School of Medicine in Israel. He completed his postdoc training in Massachusetts General Hospital Harvard Medical School and Emory University. He then worked as a Research Associate in Stanford University School of Medicine. In 2011, Dr. Deng became an Instructor of Hematology and Medical Oncology in Winship Cancer Institute at Emory University.
His research focuses on developing novel immune therapeutics against cancers; in particular, he is interested in the utilization of bioengineered fusion cytokines to reprogram patient immune cells for personalized cancer immunotherapy.
He has authored a number of peer-reviewed publications in the elite journals such as Cancer Research, Molecular Cancer, Circulation, Nature Medicine, and Nature Immunology.
Dr. Deng is the recipient of Biotechnology Scholarship Award (United Nations Education, Science and Culture Organization in Paris), Emory Winship Robbins Scholar Award, and Emory Winship Melanoma Research Fund, Winship Myeloma Fund, and Emory/Georgia Tech ImmunoEngineering Fund.